Abstract:BACKGROUND:Recently, some studies have showed that miR-200 families act as novel biomarkers for the prediction of cancer outcomes. AIMS:This meta-analysis was designed to investigate the associations between miR-200 families and the prognosis of patients with various cancers. MATERIALS & METHODS:Eligible published databases including PubMed, Embase and Chinese National Knowledge Infrastructure (CNKI) databases were searched for articles until October 18, 2016. We performed a meta-analysis by calculating pooled hazard ratios (HR) and 95% confidence intervals (CI). Data were extracted from studies comparing overall survival (OS), progression-free survival (PFS) or recurrence-free survival (RFS). RESULTS:For OS, the pooled HR was 1.54 (95% CI: 1.01-2.33), showing that high miR-200 family was clearly related to poor survival in various carcinomas, but no significantly association was found in PFS or RFS. Subgroup analysis indicated that upregulated miR-200 family was linked to poor OS in Asians (HR = 2.19, 95% CI: 1.27-3.78) but not in Caucasians (HR = 0.94, 95% CI: 0.46-1.91). Similarly, high miR-200 expression could not clearly predict the relationship with PFS and RFS. For cancer type, high miR-200 also predicted poor OS among lung cancer patients (HR = 3.09, 95% CI: 1.75-5.46). Besides, only elevated miR-200c of the miR-200 family indicated a significantly poor OS (HR = 2.25, 95% CI: 1.39-3.64). DISCUSSION:Aberrant expression of miRNAs played a crucial role in the area of human carcinomas. Many studies have indicated that miRNAs are considered promising tumor biomarkers for prognosis and potential targets for clinical treatment. We have testified that high levels of miR-200 family expression (predominantly miR-200c) are significantly associated with poor survival and prognostic outcomes of patients with cancers, especially in lung cancer. However, no statistically significant results were calculated for miR-200a/b and miR-429, and this might result from a relatively small number of articles about them. In other tumor models except lung cancer, our results indicated that high miR-200 family was not obviously associated with OS (Gastric or Colorectal cancer; Ovarian cancer; Others). In addition, some other records showed the opposite results, for they exhibited that upregulated miR-200 family level was linked to longer survival. For ethnic group, our stratified analyses showed that the Asian population predicted poor OS. While the Caucasian population did not exhibit an significant association with OS. This discrepancy might result from different hereditary backgrounds and environment exposure. Although these results have indicated that miR-200 families were promising biomarkers to predict prognosis for patients with cancers, there were several limitations in this analysis that would impact its quality. Generally, further studies should be warranted to clarify this question and to provide a new novel idea for routine clinical application. CONCLUSION:Our findings suggest that miR-200 family might be a potentially useful biomarker for predicting cancer prognosis, especially for lung cancer in Asians.

The Prognostic Significance of Microrna-221 in Hepatocellular Carcinoma: an Updated Meta-Analysis

Diagnostic Accuracy of Circulating Micrornas for Hepatitis C Virus-Associated Hepatocellular Carcinoma: a Systematic Review and Meta-Analysis

Prognostic Value of miR-222 in Various Cancers: a Systematic Review and Meta-Analysis.

Expression and prognostic significance of miR-375 and miR-221 in liver cancer

MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis

Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance

A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma

Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance

The Prognostic Value of Microrna-183 in Human Cancers A Meta-Analysis

MicroRNA-200 Families and Prognostic Value in Various Carcinomas: A Systematic Review and Meta-Analysis.

Expression of miR-221 in colon cancer correlates with prognosis.

High Expression Levels of miR-21 and miR-210 Predict Unfavorable Survival in Breast Cancer: A Systemic Review and Meta-Analysis

Prognostic value of microRNAs in patients with small cell lung cancer: a meta-analysis

The diagnostic and prognostic value of the miR-17-92 cluster in hepatocellular carcinoma: A meta-analysis.

Downregulation of Microrna-139 is Associated with Hepatocellular Carcinoma Risk and Short-Term Survival.

The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis

Prognostic Role Of Microrna-181a/B In Hematological Malignancies: A Meta-Analysis

Effects of Mirna-140 on the Growth and Clinical Prognosis of SMMC-7721 Hepatocellular Carcinoma Cell Line

Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma.

Diagnostic and Prognostic Implications of Micrornas in Human Hepatocellular Carcinoma

Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.